HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Schizophrenia and idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome)].

Abstract
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome, or GS) is a relatively common congenital hyperbilirubinemia occurring in 3-7% of the world's population. It has been recognized as a benign familial condition in which hyperbilirubinemia occurs in the absence of structural liver disease or hemolysis, and the plasma concentration of conjugated bilirubin is normal. Recently, it has been reported that unconjugated bilirubin exhibited neurotoxicity in the developing nervous system. The 'neurodevelopmental hypothesis' of schizophrenia proposes that an as-yet-unidentified event occurs in utero or during early postnatal life. We have observed that patients suffering from schizophrenia frequently present with an increased unconjugated bilirubin plasma concentration when admitted to the hospital. As a result, we noticed a relationship between unconjugated bilirubin and the etiology of, and vulnerability to, schizophrenia. Our reported findings suggest that there are significant biological and clinical character differences between schizophrenic patients with and without GS. From the viewpoint of the heterogeneity of schizophrenia, there may be a poor outcome for the subtype of schizophrenia with GS.
AuthorsTsuyoshi Miyaoka
JournalSeishin shinkeigaku zasshi = Psychiatria et neurologia Japonica (Seishin Shinkeigaku Zasshi) Vol. 113 Issue 4 Pg. 361-7 ( 2011) ISSN: 0033-2658 [Print] Japan
PMID21702127 (Publication Type: English Abstract, Journal Article)
Topics
  • Animals
  • Brain (pathology)
  • Female
  • Gilbert Disease (complications)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Rats
  • Rats, Gunn
  • Schizophrenia (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: